author-photo

Marco Colleoni

European Institute of Oncology

534

Papers

23377

Citations

Citation Trend

Filter By

Papers (379) Sort By

Journal Conference Others

Systematic review and meta-analysis of post-progression outcomes in ER+/HER2- metastatic breast cancer after treatment with endocrine therapy and CDK 4/6 inhibitors within randomized clinical trials.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations

2021 The Breast
Show All
- Source
- Cite
- Save
Citations (0)
Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer—The Penelope-B Trial

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (17)
Abstract PS12-17: Baseline characteristics of women enrolled in the POSITIVE trial (pregnancy outcome and safety of interrupting therapy for women with endocrine responsIVE breast cancer)

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy

2021
Show All
- Source
- Cite
- Save
Citations (2)
Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative.

2021 Cancer Discovery
Show All
- Source
- Cite
- Save
Citations (4)
Long‐Term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Updated Analysis With Up to 5 Years of Follow‐Up

2021 Oncologist
Show All
- Source
- Cite
- Save
Citations (4)
Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial.

2021 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Abstract PD2-09: The role of CYP2D6 mediated tamoxifen metabolism in the suppression of ovarian function trial (SOFT)

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients.

2021 Anti-Cancer Drugs
Show All
- Source
- Cite
- Save
Citations (0)